InsidersTradesSigma
Track the AN2 Therapeutics, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, AN2 Therapeutics, Inc. has recorded 132 reports. Market capitalisation: €226m. The latest transaction was filed on 19 August 2026 (Cession). Among the most active insiders: Aziz Kabeer. Every trade is free.
132
Insider Decl.
n/a
Thresholds
€17m
20 ops.
Buy Volume
€15m
50 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AN2 Therapeutics, Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$9.00.
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2026
Declarations132 total
16,696 shares@ US$6.0082Common StockSEC:0001193125-26-357225:0
18,706 shares@ US$6.0082Common StockSEC:0001193125-26-357225:1
1,012,000 shares@ US$6.00822.69% mcap95.9% of flowCommon StockSEC144:0001972481-26-000263
405,880 shares0Common StockSEC:0001193125-26-351801:0
766 shares0Common StockSEC:0001193125-26-301165:0
2,789 shares0Common StockSEC:0001193125-26-301166:0
2,852 shares0Common StockSEC:0001193125-26-301167:0
5,945 shares@ US$4.1720.015% mcap41.4% of flowCommon StockSEC:0001193125-26-301092:0
265 shares@ US$4.430.0006% mcap100.0% of flowCommon StockSEC:0001193125-26-253622:0
1,192 shares0Common StockSEC:0001193125-26-151626:0
3,775 shares0Common StockSEC:0001193125-26-151628:0
3,775 shares0Common StockSEC:0001193125-26-151632:0
327 shares@ US$1.0622.7% of flowCommon StockSEC:0001193125-26-094490:0
48,375 shares0Common StockSEC:0001193125-26-064166:0
112,250 shares0Common StockSEC:0001193125-26-064151:0
38,000 shares0Common StockSEC:0001193125-26-064141:0
50,000 shares0Common StockSEC:0001193125-26-064176:0
11,560 shares0Common StockSEC:0001193125-26-013041:0
3,650 shares0Common StockSEC:0001193125-26-013038:0
11,560 shares0Common StockSEC:0001193125-26-013035:0
3,604 shares@ US$1.00347.5% of flowCommon StockSEC:0001193125-26-006770:0
3,295 shares@ US$1.00342.2% of flowCommon StockSEC:0001193125-26-006765:0
17,923 shares@ US$1.001429.2% of flowCommon StockSEC:0001193125-26-006763:0
25 of 132 declarations
About AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for infectious diseases. The company is listed on NASDAQ under the ticker ANTX.